The biotech momentum story continues to be one of the most persistent themes over the last several years. The diversified indices that track these companies have been consistent market leaders, and investors that have stuck with these stocks have been richly rewarded.
On Thursday, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) hit a new all-time high as it surged more than 3 percent intra-day. This ETF is the largest dedicated biotech industry fund, with nearly $9 billion in total assets.
Top Biotech ETF
IBB tracks a market-cap weighted index of top healthcare names such as Gilead Sciences, Inc. (NASDAQ: GILD) and Amgen, Inc. (NASDAQ: AMGN). These companies are engaged in the fight to cure diseases and develop lifesaving drugs, but the story ...
/www.benzinga.com/general/biotech/15/06/5606677/biotech-etfs-hit-new-2015-highs alt=Biotech ETFs Hit New 2015 Highs>Full story available on Benzinga.com
More...